Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

387 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Guselkumab effectiveness and survival in patients with psoriasis and psoriatic arthritis: Multicenter analysis in daily clinical practice by the Spanish Psoriasis Group.
Rocamora V, Crespi L, Ferran M, Llamas-Velasco M, Del Alcázar E, Carrascosa JM, Beltran E, Urruticoechea-Arana A, Estebaranz JLL, Vidal D, Riera J, Rodríguez L, Armesto S, Fernández JM, Aparicio G, Pérez S, Porcar S, Montesinos E, Gallardo F. Rocamora V, et al. Among authors: vidal d. Dermatol Ther. 2022 Nov;35(11):e15865. doi: 10.1111/dth.15865. Epub 2022 Oct 9. Dermatol Ther. 2022. PMID: 36175141
[Adverse reactions during biological therapy for psoriasis: results of a survey of the Spanish Psoriasis Group].
Sánchez-Regaña M, Dilmé E, Puig L, Bordas X, Carrascosa JM, Ferran M, Herranz P, García-Bustinduy M, López Estebaranz JL, Alsina M, Rodríguez MA, Ribera M, Fernández-López E, Moreno JC, Belinchón Romero I, Vidal D; Grupo Español de Psoriasis de la Academia Española. Sánchez-Regaña M, et al. Among authors: vidal d. Actas Dermosifiliogr. 2010 Mar;101(2):156-63. Actas Dermosifiliogr. 2010. PMID: 20223158 Spanish.
[Narrowband UV-B, monochromatic excimer laser, and photodynamic therapy in psoriasis: a consensus statement of the Spanish Psoriasis Group].
Carrascosa JM, López-Estebaranz JL, Carretero G, Daudén E, Ferrándiz C, Vidal D, Belinchón I, Sánchez-Regaña M, Puig L; Grupo Español de Psoriasis de la Academia Española de Dermatología y Venereología. Carrascosa JM, et al. Among authors: vidal d. Actas Dermosifiliogr. 2011 Apr;102(3):175-86. doi: 10.1016/j.ad.2010.11.002. Actas Dermosifiliogr. 2011. PMID: 21310368 Free article. Spanish.
Methotrexate in Moderate to Severe Psoriasis: Review of the Literature and Expert Recommendations.
Carrascosa JM, de la Cueva P, Ara M, Puig L, Bordas X, Carretero G, Ferrándiz L, Sánchez-Carazo JL, Daudén E, López-Estebaranz JL, Vidal D, Herranz P, Jorquera E, Coto-Segura P, Ribera M. Carrascosa JM, et al. Among authors: vidal d. Actas Dermosifiliogr. 2016 Apr;107(3):194-206. doi: 10.1016/j.ad.2015.10.005. Epub 2015 Nov 21. Actas Dermosifiliogr. 2016. PMID: 26614486 Free article. Review. English, Spanish.
Guidelines on the Use of Methotrexate in Psoriasis.
Carretero G, Puig L, Dehesa L, Carrascosa JM, Ribera M, Sánchez-Regaña M, Daudén E, Vidal D, Alsina M, Muñoz-Santos C, López-Estebaranz JL, Notario J, Ferrandiz C, Vanaclocha F, García-Bustinduy M, Taberner R, Belinchón I, Sánchez-Carazo J, Moreno JC; Grupo de Psoriasis de la AEDV. Carretero G, et al. Among authors: vidal d. Actas Dermosifiliogr. 2010 Sep;101(7):600-613. doi: 10.1016/j.ad.2010.04.002. Epub 2010 Jul 31. Actas Dermosifiliogr. 2010. PMID: 28709542 English, Spanish.
Treatment of patients with plaque psoriasis with secukinumab in a real-life setting: a 52-week, multicenter, retrospective study in Spain.
Notario J, Deza G, Vilarrasa E, Valentí F, Muñoz C, Mollet J, Rocamora V, Carrascosa JM, Del Alcázar E, Alsina M, Vidal D, Puig L, López-Ferrer A, Riera J, Gallardo F, Ferran M. Notario J, et al. Among authors: vidal d. J Dermatolog Treat. 2019 Aug;30(5):424-429. doi: 10.1080/09546634.2018.1528000. Epub 2018 Dec 3. J Dermatolog Treat. 2019. PMID: 30244618 Free article.
Initial results of ixekizumab efficacy and safety in real-world plaque psoriasis patients: a multicentre retrospective study.
Deza G, Notario J, Lopez-Ferrer A, Vilarrasa E, Ferran M, Del Alcazar E, Carrascosa JM, Corral M, Salleras M, Ribera M, Puig L, Pujol RM, Vidal D, Gallardo F. Deza G, et al. Among authors: vidal d. J Eur Acad Dermatol Venereol. 2019 Mar;33(3):553-559. doi: 10.1111/jdv.15288. Epub 2018 Nov 13. J Eur Acad Dermatol Venereol. 2019. PMID: 30317679
Effectiveness and safety of ustekinumab 90 mg in patients weighing 100 kg or less: a retrospective, observational, multicenter study.
Del Alcázar E, Ferran M, López-Ferrer A, Notario J, Vidal D, Riera J, Aparicio G, Gallardo F, Vilarrasa E, Alsina M, Puig L, Ferrándiz C, Carrascosa JM. Del Alcázar E, et al. Among authors: vidal d. J Dermatolog Treat. 2020 May;31(3):222-226. doi: 10.1080/09546634.2019.1597245. Epub 2019 Apr 2. J Dermatolog Treat. 2020. PMID: 30883242 Free article.
Real-world effectiveness and safety of apremilast in psoriasis at 52 weeks: a retrospective, observational, multicentre study by the Spanish Psoriasis Group.
Del Alcázar E, Suárez-Pérez JA, Armesto S, Rivera R, Herrera-Acosta E, Herranz P, Martín I, Montesinos E, Hospital M, Vilarrasa E, Ferran M, Ruiz-Villaverde R, Sahuquillo-Torralba A, Ruiz-Genao DP, Pérez-Barrio S, Muñoz C, Llamas M, Valentí F, Mitxelena MJ, López-Ferrer A, Carretero G, Vidal D, Mollet J, Belinchón I, Carrascosa JM. Del Alcázar E, et al. Among authors: vidal d. J Eur Acad Dermatol Venereol. 2020 Dec;34(12):2821-2829. doi: 10.1111/jdv.16439. Epub 2020 Jun 17. J Eur Acad Dermatol Venereol. 2020. PMID: 32271966
387 results